| Direct Competitor Comparison | |
|---|
| TZYM | IRWD | PVT1 | THRX | Industry |
|---|
| Market Cap: | 16.30M | 1.35B | N/A | 3.66B | 64.52B |
|---|
| Employees: | 29 | 530 | N/A | 226 | 99.49k |
|---|
| Qtrly Rev Growth (yoy): | -0.77 | -0.73 | N/A | -0.99 | 0.11 |
|---|
| Revenue (ttm):
| 6.44M | 141.25M | N/A | 10.00M | 27.01B |
|---|
| Gross Margin (ttm): | 1.00 | 0.71 | N/A | N/A | 0.61 |
|---|
| EBITDA (ttm): | -14.68M | -114.53M | N/A | -125.11M | 10.37B |
|---|
| Operating Margin (ttm):
| -2.33 | -0.89 | N/A | -13.24 | 0.16 |
|---|
| Net Income (ttm): | -17.82M | -130.93M | N/A | -140.50M | N/A |
|---|
| EPS (ttm): | -0.68 | -1.22 | N/A | -1.51 | 3.27 |
|---|
| P/E (ttm): | N/A | N/A | N/A | N/A | 14.20 |
|---|
| PEG (5 yr expected): | N/A | N/A | N/A | 0.11 | 0.96 |
|---|
| P/S (ttm): | 2.53 | 9.58 | N/A | 365.68 | 2.23 |
|---|
|
| IRWD = Ironwood Pharmaceuticals, Inc. | | Pvt1 = Prometheus Laboratories Inc. (privately held) | | THRX = Theravance Inc. | | Industry = Drug Manufacturers - Major | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.62 | 0.00 | 79.21B | 17.88 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 232.62 | 0.00 | 55.22B | 36.91 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 55.48 | 0.00 | 84.63B | 31.06 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 73.94 | 0.00 | 12.72B | 31.30 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.49 | 0.00 | 33.65B | 19.72 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 128.08 | 0.00 | 16.36B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.75 | 0.00 | 12.10B | 21.21 |
|---|
| Pfizer Inc. | PFE | 29.11 | 0.00 | 206.48B | 13.93 |
|---|
| Johnson & Johnson | JNJ | 87.21 | 0.00 | 244.96B | 23.69 |
|---|
| GlaxoSmithKline plc | GSK | 52.73 | 0.00 | 127.71B | 19.27 |
|---|
| Sanofi | SNY | 54.56 | 0.00 | 144.41B | 26.89 |
|---|
| Novartis AG | NVS | 73.82 | 0.00 | 181.39B | 18.74 |
|---|
| Roche Holding AG | RHHBY | 65.56 | 0.00 | 222.50B | 21.94 |
|---|
| AstraZeneca PLC | AZN | 52.08 | 0.00 | 65.10B | 11.52 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.48 | 0.00 | 58.43B | 11.42 |
|---|
| Bristol-Myers Squibb Company | BMY | 47.00 | 0.00 | 77.20B | 53.23 |
|---|
|
| News on Direct Competitors | |
|---|
- THRX
- Royalty Pharma eases condition for Elan offer AP Thu 5:17pm
- THRX
- Theravance to Present at Investor Conferences in June 2013 Marketwired Thu 4:05pm
- THRX
- Elan rejects Royalty's $6.4 billion raised offer Reuters Thu 1:36pm
- IRWD
- Ironwood Pharma Prices Stock Offering Zacks Thu 11:35am
- IRWD
- Grab IRWD Even Cheaper Than Its Secondary? at Forbes Thu 10:08am
- IRWD
- Ironwood Pharmaceuticals Is Now Oversold (IRWD) at TheStreet Wed, May 22
- IRWD
- Ironwood Pharmaceuticals Prices Public Offering of Common Stock Business Wire Tue, May 21
- IRWD
- Synergy Is A Straightforward Opportunity: Trial Results At DDW Back Plecanatide at Seeking Alpha Tue, May 21
- THRX
- Today’s Research on HSP, ALKS, CLSN, THRX, and CHTP Accesswire Mon, May 13
- THRX
- Hot Movers: Federal National Mortgage Association, Federal Home Loan Mortgage, Theravance Inc, Life Technologies Corp Accesswire Mon, Apr 15
All headlines for these symbols... Currency in USD. | |
|
0.74%